Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Inducing Apoptosis and Decreases Cell Proliferation in Human Breast Cancer Cells Through Mir-182-5P Blockage Caused by Locked Nucleic Acid



Sharifi M1 ; Moridnia A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Isfahan Medical School Published:2017

Abstract

Background: MicroRNAs (miRNAs) are single strand and short non-coding RNAs involved in post-transcription expression of genes. MiRNAs exhibited a substantial role in numerous cellular processes including cell proliferation, differentiation, cell cycle, apoptosis, and cancer development by negative regulation of tumor suppressor or oncogenic genes. Breast cancer is one of the most common cancers in world. Several studies reveal that miR-182-5p is up-regulated in breast cancer. Methods: MiR-182-5p blockage was performed using locked nucleic acid (LNA) technology in human breast cancer cell line (MCF-7). After blockage, miR-182-5p expression, cell proliferation, apoptosis and necrosis were measured. MiR-182-5p expression was assessed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) at 24, 48, and 72 hour after locked nucleic acid anti-miR-182-5p transfection. Moreover, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and annexin/propidium iodide staining were evaluated. Findings: MiR-182-5p expression decreased at 24, 48, and 72 hours after transfection in the locked nucleic acid group compared to control groups. Cell viability was statistically different between locked nucleic acid and control groups. In the locked nucleic acid group, due to miR-182-5p inhibition, apoptosis ratio increased more than the other groups. Similarly, necrosis ratio in the locked nucleic acid group increased more than the other groups. Conclusion: In this study, miR-182-5p blockage reduced cell viability in MCF-7 cells chiefly due to induction of apoptosis and necrosis. Our results can help translational medicine for investigation on antisense therapy in human breast cancer. © 2017, Isfahan University of Medical Sciences(IUMS). All rights reserved.
Related Docs
View other Related Docs
1. Apoptosis-Inducing and Antiproliferative Effect by Inhibition of Mir-182-5P Through the Regulation of Casp9 Expression in Human Breast Cancer, Cancer Gene Therapy (2017)
2. Apoptosis Induction in Acute Promyelocytic Leukemia Cells Through Upregulation of Cebpα by Mir-182 Blockage, Molecular Biology Research Communications (2018)
3. Inducing Cell Proliferative Prevention in Human Acute Promyelocytic Leukemia by Mir-182 Inhibition Through Modulation of Casp9 Expression, Biomedicine and Pharmacotherapy (2017)
4. Emerging Biologic and Clinical Implications of Mir-182-5P in Gynecologic Cancers, Clinical and Translational Oncology (2024)
5. Mir-370 Expression Analysis in Breast Cancer, Journal of Isfahan Medical School (2015)
6. Blockage of Mir-92A-3P With Locked Nucleic Acid Induces Apoptosis and Prevents Cell Proliferation in Human Acute Megakaryoblastic Leukemia, Cancer Gene Therapy (2016)
7. Inducing Apoptosis and Decreasing Cell Proliferation in Human Acute Promyelocytic Leukemia Through Regulation Expression of Casp3 by Let-7A-5P Blockage, Indian Journal of Hematology and Blood Transfusion (2018)
8. Degradation of Mir-21 Induces Apoptosis and Inhibits Cell Proliferation in Human Hepatocellular Carcinoma, Cancer Gene Therapy (2015)
Experts (# of related papers)
View all Related Experts
Mohammadreza Sharifi (22)
Rasoul Salehi (8)
Other Related Docs
9. Inhibition of Microrna-21 Via Locked Nucleic Acid-Anti-Mir Suppressed Metastatic Features of Colorectal Cancer Cells Through Modulation of Programmed Cell Death 4, Tumor Biology (2017)
10. Inhibition of Microrna Mir-92A Inhibits Cell Proliferation in Human Acute Promyelocytic Leukemia; [Mikrorna Mir-92A Inhibisyonu Insan Akut Promyelositik Losemide Hucre Proliferasyonunu Inhibe Eder], Turkish Journal of Hematology (2013)
11. Knockdown of Sirlnt by Antisense Lna Gapmers and Evaluation of Its Inhibitory Effect on Proliferation and Apoptosis in Mcf7 Cell Line, Indian Journal of Gynecologic Oncology (2023)
12. Locked Nucleic Acid Inhibits Mir-92A-3P in Human Colorectal Cancer, Induces Apoptosis and Inhibits Cell Proliferation, Cancer Gene Therapy (2016)
13. Dysregulated Expression and Functions of Microrna-330 in Cancers: A Potential Therapeutic Target, Biomedicine and Pharmacotherapy (2022)
14. Regulating Mirnas Expression by Resveratrol: Novel Insights Based on Molecular Mechanism and Strategies for Cancer Therapy, Current Molecular Pharmacology (2024)
15. Bioinformatics Prediction and Experimental Validation of a Novel Microrna: Hsa-Mir-B43 Within Human Cdh4 Gene With a Potential Metastasis-Related Function in Breast Cancer, Journal of Cellular Biochemistry (2020)
16. Mir-195 Down-Regulation Is a Distinctive Biomarker of Her2 Positive State in Breast Cancer, Gene Reports (2020)
17. Pi3k/Akt/Mtor Signaling Pathway Modulation by Circular Rnas in Breast Cancer Progression, Pathology Research and Practice (2023)
18. Opposite Trends of Gas6 and Gas6-As Expressions in Breast Cancer Tissues, Experimental and Molecular Pathology (2021)
19. Suppression of Nicotinamide Phosphoribosyltransferase Expression by Mir-154 Reduces the Viability of Breast Cancer Cells and Increases Their Susceptibility to Doxorubicin, BMC Cancer (2019)
20. Inhibition of Microrna Mir-222 With Lna Inhibitor Can Reduce Cell Proliferation in B Chronic Lymphoblastic Leukemia, Indian Journal of Hematology and Blood Transfusion (2017)
21. Cancer-Associated Fibroblasts Regulate the Plasticity of Breast Cancer Stemness Through the Production of Leukemia Inhibitory Factor, Life (2021)
22. Locked Nucleic Acid Anti-Mir-21 Inhibits Cell Growth and Invasive Behaviors of a Colorectal Adenocarcinoma Cell Line: Lna-Anti-Mir As a Novel Approach, Cancer Gene Therapy (2016)
23. Downregulation of Mir100hg Induces Apoptosis in Human Megakaryoblastic Leukemia Cells, Indian Journal of Hematology and Blood Transfusion (2021)
24. Evaluation of Silencing Effect of Mir-133A-5P Mimic on Tim-3 Expression in Aml (Hl-60) Cell Line, Indian Journal of Clinical Biochemistry (2020)
25. The Effect of Decitabine on the Expression and Methylation of the Ppp1ca, Btg2, and Pten in Association With Changes in Mir-125B, Mir-17, and Mir-181B in Nalm6 Cell Line, Journal of Cellular Biochemistry (2019)
26. Modulation of Long Non-Coding Rnas and Micrornas by Quercetin As a Potential Therapeutical Approach in Cancer: A Comprehensive Review, Current medicinal chemistry (2025)
27. Current Status and Perspectives Regarding Lna-Anti-Mir Oligonucleotides and Microrna Mir-21 Inhibitors As a Potential Therapeutic Option in Treatment of Colorectal Cancer, Journal of Cellular Biochemistry (2017)
28. Dna Methylation and Microrna Patterns Are in Association With the Expression of Brca1 in Ovarian Cancer, Cellular and Molecular Biology (2016)
29. Leukemia Inhibitory Factor: A Main Controller of Breast Cancer, Journal of Biosciences (2020)
30. Gene Expression Profiles of Cyp24a1 and Cyp27b1 in Malignant and Normal Breast Tissues, Molecular Medicine Reports (2017)
31. Microrna-200C Overexpression in Cancer-Associated Fibroblasts Reduces the Invasive Properties of Breast Tumour Cells, Clinical and Translational Discovery (2022)
32. Comparison of Mir-211 Expression in Murine Melanoma Cell Line and Murine Melanoma Tumor by Real-Time Polymerase Chain Reaction, Journal of Isfahan Medical School (2012)
33. Evaluation of the Effect of Tim-3 Suppression by Mir-498 and Its Effect on Apoptosis and Proliferation Rate of Hl-60 Cell Line, Pathology Research and Practice (2018)
34. Therapeutic Inhibition of Microrna-21 (Mir-21) Using Locked-Nucleic Acid (Lna)-Anti-Mir and Its Effects on the Biological Behaviors of Melanoma Cancer Cells in Preclinical Studies, Cancer Cell International (2020)
35. The Role of Mir-16 and Mir-34A Family in the Regulation of Cancers: A Review, Heliyon (2025)
36. Mir-574, Mir-499, Mir-125B, Mir-106A, and Mir-9 Potentially Target Tgfbr-1 and Tgfbr-2 Genes Involving in Inflammatory Response Pathway: Potential Novel Biomarkers for Chronic Lymphocytic Leukemia, Pathology Research and Practice (2022)
37. In Silico Identification and in Vitro Evaluation of Mrps30-Dt Lncrna and Mrps30 Gene Expression in Breast Cancer, Cancer Reports (2024)
38. Frequent Esr1 and Cdk Pathway Copy-Number Alterations in Metastatic Breast Cancer, Molecular Cancer Research (2019)
39. The Function and Mechanism of Circrnas in 5-Fluorouracil Resistance in Tumors: Biological Mechanisms and Future Potential, Pathology Research and Practice (2024)
40. A Review on Expression and Regulatory Mechanisms of Mir-337-3P in Cancer, Journal of Biomolecular Structure and Dynamics (2024)
41. The Mir-125A-3P Inhibits Tim-3 Expression in Aml Cell Line Hl-60 in Vitro, Indian Journal of Hematology and Blood Transfusion (2017)
42. Lna Inhibitor in Microrna Mir-23B As a Potential Anti-Proliferative Option in Human Hepatocellular Carcinoma, Journal of Gastrointestinal Cancer (2020)
43. The Role of Lncrna Mcm3ap-As1 in Human Cancer, Clinical and Translational Oncology (2023)
44. The Cytotoxicity of 27-Hydroxycholesterol in Mcf-7 and Mda-Mb-231, Advanced Biomedical Research (2023)
45. Mir-939, As an Important Regulator in Various Cancers Pathogenesis, Has Diagnostic, Prognostic, and Therapeutic Values: A Review, Journal of the Egyptian National Cancer Institute (2024)
46. Plasma Level of Mir-21 and Mir-451 in Primary and Recurrent Breast Cancer Patients, Breast Cancer: Targets and Therapy (2019)
47. Reduce Proliferation of Human Bone Marrow Cells From Acute Myeloblastic Leukemia With Minimally Differentiation by Blocking Lncrna Pvt1, Clinical and Translational Oncology (2020)
48. Antiproliferative Effect of Upregulation of Hsa-Let-7C-5P in Human Acute Erythroleukemia Cells, Cytotechnology (2018)
49. The Upregulation of Hsa-Mir-181B-1 and Downregulation of Its Target Cyld in the Late-Stage of Tumor Progression of Breast Cancer, Indian Journal of Clinical Biochemistry (2020)
50. Circulating Microrna-192 As a Diagnostic Biomarker in Human Chronic Lymphocytic Leukemia, Cancer Gene Therapy (2016)